Skip to main content

Home/ Cancer/ Group items matching "200" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Four times current vitamin D doses needed for winter levels: Study - 0 views

www.nutraingredients.com/...needed-for-winter-levels-Study

2009 March nutraingredients news vitamin D vitamin_D dose doses dosing dosage winter nutrition supplements supplementation osteopenia osteoporosis muscle_weakness fractures cancer autoimmune_diseases CVD infections diabetes type_1

shared by Matti Narkia on 10 Mar 09 - No Cached
  • Matti Narkia on 10 Mar 09
     
    Maintaining adequate levels of vitamin D during winter months requires a daily dose of 20 micrograms, four times the current recommended dose, says a new study. The study, led by Susan Sullivan from the University of Maine, has important implications for ongoing consultations on vitamin D recommendations, with the current level of five micrograms (200 International Units) seen by many as insufficient.
Matti Narkia

Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model, July 2003, Cox et al. 129 (7): 781 -- Arch Otolaryngol Head Neck Surg - 0 views

archotol.ama-assn.org/...781

Inhibition Growth Squamous Cell Carcinoma Tetrathiomolybdate Copper Suppression cancer anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis inhibitor inhibitors reduction head neck scc medicine medline science study research head_and_nec SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    C. Cox, S. D. Merajver, S. Yoo, R. D. Dick, G. J. Brewer, J. S.-J. Lee, and T. N. Teknos Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model Arch Otolaryngol Head Neck Surg, July 1, 200
Matti Narkia

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck: A Phase 2 Trial, March 2000, Barrera et al. 126 (3): 345 - Arch Otolaryngol Head Neck Surg - 0 views

archotol.ama-assn.org/...345

200 March study research clinical_trial phase_II phase_II_trial humans head_and_neck cancer head_and_neck_cancer scchn nhca scc natural cytokine mixture IRX-2 Hadden low-dose cyclophosphamide indomethacin zinc contrasuppression immunotherapy nutrition med

shared by Matti Narkia on 10 Apr 09 - Cached
  • Matti Narkia on 10 Apr 09
     
    Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial. Barrera JL, Verastegui E, Meneses A, Zinser J, de la Garza J, Hadden JW. Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):345-51. PMID: 10722007
1 - 3 of 3
Showing 20▼ items per page